Baxter International Inc. (LON:0QK8)
24.15
-0.20 (-0.82%)
At close: Aug 15, 2025
Baxter International Revenue
Baxter International had revenue of $2.81B USD in the quarter ending June 30, 2025, with 4.31% growth. This brings the company's revenue in the last twelve months to $10.89B, up 3.60% year-over-year. In the year 2024, Baxter International had annual revenue of $10.64B with 2.66% growth.
Revenue (ttm)
$10.89B
Revenue Growth
+3.60%
P/S Ratio
1.16
Revenue / Employee
$286.50K
Employees
38,000
Market Cap
9.26B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.64B | 276.00M | 2.66% |
Dec 31, 2023 | 10.36B | 303.00M | 3.01% |
Dec 31, 2022 | 10.06B | -2.09B | -17.20% |
Dec 31, 2021 | 12.15B | 473.00M | 4.05% |
Dec 31, 2020 | 11.67B | 311.00M | 2.74% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Oxford Nanopore Technologies | 183.19M |
Baxter International News
- 18 days ago - Novo Nordisk, United Parcel Service, And Moderna Are Among Top 10 Large Cap Losers Last Week (July 28-August 1): Are The Others In Your Portfolio? - Benzinga
- 20 days ago - Baxter cut to Neutral at Goldman Sachs after Q2 miss - Seeking Alpha
- 20 days ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields - Benzinga
- 20 days ago - Baxter (BAX) Q2 Revenue Rises 4% - The Motley Fool
- 21 days ago - Hospital Product Maker Baxter Stock Plunges On Trimmed Annual Outlook - Benzinga
- 21 days ago - Hospital Product Maker Baxter Stock Plunges On Trimmed Annual Outlook - Benzinga
- 21 days ago - This Is What Whales Are Betting On Baxter Intl - Benzinga
- 21 days ago - Baxter International Inc. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha